Intersect ENT, Inc. Available-for-sale Securities, Amortized Cost Basis
Intersect ENT, Inc. had Available-for-sale Securities, Amortized Cost Basis of $90.58 million as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2020-02-27
- 2019-12-31: Available-for-sale Securities, Amortized Cost Basis $90.58M.
- 2019-09-30: Available-for-sale Securities, Amortized Cost Basis $89.13M.
- 2019-06-30: Available-for-sale Securities, Amortized Cost Basis $93.38M.
- 2019-03-31: Available-for-sale Securities, Amortized Cost Basis $97.55M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2019-12-31 | $90.58M 10-K · filed 2020-02-27 |
| 2019-09-30 | $89.13M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $93.38M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $97.55M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $100.81M 10-K · filed 2020-02-27 |
| 2018-09-30 | $104.06M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $104.98M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $103.40M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $102.41M 10-K · filed 2019-02-28 |
| 2017-09-30 | $102.52M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $100.07M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $98.40M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $103.98M 10-K · filed 2018-02-28 |
| 2016-09-30 | $108.57M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $111.64M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $116.90M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $124.29M 10-K · filed 2017-02-28 |
| 2015-09-30 | $131.08M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $136.51M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $42.91M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $48.44M 10-K · filed 2016-02-25 |
| 2014-09-30 | $53.61M 10-Q · filed 2014-11-10 |
| 2013-12-31 | $12.29M 10-K · filed 2015-03-11 |